These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
577 related articles for article (PubMed ID: 3037521)
1. Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines. Masucci MG; Torsteindottir S; Colombani J; Brautbar C; Klein E; Klein G Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4567-71. PubMed ID: 3037521 [TBL] [Abstract][Full Text] [Related]
2. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells. Masucci MG; Zhang QJ; Gavioli R; De Campos-Lima PO; Murray RJ; Brooks J; Griffin H; Ploegh H; Rickinson AB Int Immunol; 1992 Nov; 4(11):1283-92. PubMed ID: 1282031 [TBL] [Abstract][Full Text] [Related]
3. Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma. Gavioli R; De Campos-Lima PO; Kurilla MG; Kieff E; Klein G; Masucci MG Proc Natl Acad Sci U S A; 1992 Jul; 89(13):5862-6. PubMed ID: 1321426 [TBL] [Abstract][Full Text] [Related]
4. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression. Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641 [TBL] [Abstract][Full Text] [Related]
5. Differentiation-dependent sensitivity of human B-cell-derived lines to major histocompatibility complex-restricted T-cell cytotoxicity. Torsteinsdottir S; Masucci MG; Ehlin-Henriksson B; Brautbar C; Ben Bassat H; Klein G; Klein E Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5620-4. PubMed ID: 3016710 [TBL] [Abstract][Full Text] [Related]
6. Combined treatment with interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha up-regulates the expression of HLA class I determinants in Burkitt lymphoma lines. Avila-Carino J; Torsteinsdottir S; Bejarano MT; Klein G; Klein E; Masucci MG Cell Immunol; 1988 Dec; 117(2):303-11. PubMed ID: 2848629 [TBL] [Abstract][Full Text] [Related]
7. Stimulation with allogeneic Epstein-Barr virus-transformed lymphoblastoid cell lines generates HLA class I-specific CTLs with different target cell avidity. Torsteinsdottir S; Cuomo L; Klein E; Masucci MG Cell Immunol; 1991 Oct; 137(2):501-13. PubMed ID: 1654213 [TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus-specific cytotoxic T-cell recognition of transfectants expressing the virus-coded latent membrane protein LMP. Murray RJ; Wang D; Young LS; Wang F; Rowe M; Kieff E; Rickinson AB J Virol; 1988 Oct; 62(10):3747-55. PubMed ID: 2843672 [TBL] [Abstract][Full Text] [Related]
9. T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutation of anchor residues. de Campos-Lima PO; Levitsky V; Brooks J; Lee SP; Hu LF; Rickinson AB; Masucci MG J Exp Med; 1994 Apr; 179(4):1297-305. PubMed ID: 7511684 [TBL] [Abstract][Full Text] [Related]
10. Generation of HLA-B55 restricted T lymphocyte mediated cytotoxicity against autologous LCL. Avila-Cariño J; Végh Z; Klein E Mol Immunol; 1994 Jan; 31(1):59-63. PubMed ID: 8302299 [TBL] [Abstract][Full Text] [Related]
11. Selective induction of allostimulatory capacity after 5-azaC treatment of EBV carrying but not EBV negative Burkitt lymphoma cell lines. Cuomo L; Trivedi P; de Campos-Lima PO; Zhang QJ; Ragnar E; Klein G; Masucci MG Mol Immunol; 1993 Apr; 30(5):441-50. PubMed ID: 7681932 [TBL] [Abstract][Full Text] [Related]
12. Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice. Lacerda JF; Ladanyi M; Louie DC; Fernandez JM; Papadopoulos EB; O'Reilly RJ J Exp Med; 1996 Mar; 183(3):1215-28. PubMed ID: 8642263 [TBL] [Abstract][Full Text] [Related]
13. Restoration of the LFA-3 adhesion pathway in Burkitt's lymphoma cells using an LFA-3 recombinant vaccinia virus: consequences for T cell recognition. Griffin H; Rowe M; Murray R; Brooks J; Rickinson A Eur J Immunol; 1992 Jul; 22(7):1741-8. PubMed ID: 1378014 [TBL] [Abstract][Full Text] [Related]
14. Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised. Hill AB; Lee SP; Haurum JS; Murray N; Yao QY; Rowe M; Signoret N; Rickinson AB; McMichael AJ J Exp Med; 1995 Jun; 181(6):2221-8. PubMed ID: 7539044 [TBL] [Abstract][Full Text] [Related]
15. Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance. Gregory CD; Murray RJ; Edwards CF; Rickinson AB J Exp Med; 1988 Jun; 167(6):1811-24. PubMed ID: 2898508 [TBL] [Abstract][Full Text] [Related]
16. CD4+ T cell-induced differentiation of EBV-transformed lymphoblastoid cells is associated with diminished recognition by EBV-specific CD8+ cytotoxic T cells. Khanolkar A; Fu Z; Underwood LJ; Bondurant KL; Rochford R; Cannon MJ J Immunol; 2003 Mar; 170(6):3187-94. PubMed ID: 12626577 [TBL] [Abstract][Full Text] [Related]
17. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line. Gregory CD; Rowe M; Rickinson AB J Gen Virol; 1990 Jul; 71 ( Pt 7)():1481-95. PubMed ID: 2165133 [TBL] [Abstract][Full Text] [Related]
18. Identification of a cytotoxic T-lymphocyte response to the novel BARF0 protein of Epstein-Barr virus: a critical role for antigen expression. Kienzle N; Sculley TB; Poulsen L; Buck M; Cross S; Raab-Traub N; Khanna R J Virol; 1998 Aug; 72(8):6614-20. PubMed ID: 9658107 [TBL] [Abstract][Full Text] [Related]
20. HLA-A alleles of patients with pyothorax-associated lymphoma: anti-Epstein-Barr virus (EBV) host immune responses during the development of EBV latent antigen-positive lymphomas. Kanno H; Ohsawa M; Hashimoto M; Iuchi K; Nakajima Y; Aozasa K Int J Cancer; 1999 Aug; 82(5):630-4. PubMed ID: 10417757 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]